
Acrivastine
CAS No. 87848-99-5
Acrivastine ( Acrivastine | BW 825C )
产品货号. M19216 CAS No. 87848-99-5
阿伐斯汀是一种短效组胺 1 受体拮抗剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥251 | 有现货 |
![]() ![]() |
10MG | ¥381 | 有现货 |
![]() ![]() |
25MG | ¥810 | 有现货 |
![]() ![]() |
50MG | ¥1320 | 有现货 |
![]() ![]() |
100MG | ¥1887 | 有现货 |
![]() ![]() |
500MG | ¥4722 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Acrivastine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述阿伐斯汀是一种短效组胺 1 受体拮抗剂。
-
产品描述Acrivastine is an antihistamine with reduced sedating potential.(In Vivo):Acrivastine (usually 8mg three times daily) is an effective and well tolerated antihistamine in the treatment of chronic urticaria and allergic rhinitis. Acrivastine is more effective than placebo and similar in efficacy to clemastine or terfenadine in the treatment of seasonal allergic rhinitis. In the treatment of dermatoses in which histamine has a pathogenetic role, the efficacy of acrivastine is superior to that of placebo and similar to that of usual dosages of clemastine, hydroxyzine, chlorpheniramine, cyproheptadine or terfenadine. Acrivastine causes less drowsiness than clemastine, the incidence of adverse effects being indistinguishable from that with placebo or terfenadine. Both 4 mg and 8 mg acrivastine alleviate the symptoms of seasonal allergic rhinitis with significant improvements in the symptom scores for sneezing, running nose and the calculated overall score. In addition, 8 mg acrivastine reduces the symptom scores for watery eyes and itchy throat. Acrivastine is both well tolerated and effective in the treatment of seasonal allergic rhinitis.
-
体外实验——
-
体内实验Acrivastine (usually 8mg three times daily) is an effective and well tolerated antihistamine in the treatment of chronic urticaria and allergic rhinitis. Acrivastine is more effective than placebo and similar in efficacy to clemastine or terfenadine in the treatment of seasonal allergic rhinitis. In the treatment of dermatoses in which histamine has a pathogenetic role, the efficacy of acrivastine is superior to that of placebo and similar to that of usual dosages of clemastine, hydroxyzine, chlorpheniramine, cyproheptadine or terfenadine. Acrivastine causes less drowsiness than clemastine, the incidence of adverse effects being indistinguishable from that with placebo or terfenadine. Both 4 mg and 8 mg acrivastine alleviate the symptoms of seasonal allergic rhinitis with significant improvements in the symptom scores for sneezing, running nose and the calculated overall score. In addition, 8 mg acrivastine reduces the symptom scores for watery eyes and itchy throat. Acrivastine is both well tolerated and effective in the treatment of seasonal allergic rhinitis.
-
同义词Acrivastine | BW 825C
-
通路Others
-
靶点Other Targets
-
受体H1 receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number87848-99-5
-
分子量348.44
-
分子式C22H24N2O2
-
纯度>98% (HPLC)
-
溶解度DMSO : 10.45 mg/mL 29.99 mM
-
SMILESCc1ccc(cc1)C(=C/CN1CCCC1)\c1cccc(\C=C\C(O)=O)n1
-
化学全称2-Propenoic acid, 3-(6-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-2-pyridinyl)-, (E,E)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Brogden RN, et al. Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Drugs. 1991 Jun;41(6):927-40.
产品手册




关联产品
-
Cimicifugic acid F
Cimicifugic acid F has antioxidant activity. Cimicifugic acid F shows inhibition of neutrophil elastase activity with an IC50 of 18 mumol/L.
-
Chaetocin
Chaetocin 是毛壳属物种的天然产物,是一种组蛋白甲基转移酶抑制剂,对 dSU(VAR)3-9、小鼠 G9a 和 Neurospora crassa DIM5 的 IC50 分别为 0.8 μM、2.5 μM 和 3 μM。
-
Glucoarabin
The seeds of Raphanus sativus L.